Biobanking Market by Product & Services (Equipment, Consumables, Services and Softwares), Sample Type (Blood Products & Services, Biological Fluids, Cell Lines, Human Tissues, Nucleic Acids), Storage Type (Automated, Manual), Application (Clinical Research, Life Science Research, Regenerative Medicine) – Analysis and Forecast 2019-2030

Report ID : 76  |  Published Date : May 2019  |  Pages : 150  |  Region : Global  |  Report Code : BT-14




Biobanking Market Overview and Introduction

The Biobanking Market is estimated to be over US$ 1,900 Mn in 2018. It is anticipated to grow at a Sustainable CAGR from 2019 to 2030.

The biobank is a repository that holds biological samples which bear significance in the field of medicine and research. Biobank consists of biospecimens such as purified blood, plasma, saliva, DNA samples, and many others. It provides data necessary for the analysis of various aspects of diseases, which helps to treat them. Several chronic diseases such as cancer, neurological disorders, immunological disorders, can be treated with the help of biobanks.

The global biobanking market is driven by a high incidence of chronic diseases such as cardiovascular disease, Alzheimer’s disease, arthritis, and diabetes. Moreover, factors such as an increase in R& D funding, technological advancements in regenerative medicine, developments in drug discovery and increasing awareness about stem cell therapies. The increasing number of research activities used for predicting drug reactions is expected to support the growth of this market.

Biobanking Market by Product & Services

Based on the product, the market is segmented into equipment, consumables, services, and software. The equipment accounts for the highest share in the revenue owing to the increasing number of biobanks around the world, which in turn, demand more instruments for use.

Biobanking Market by Sample Type

On the basis of the sample, the biobanking market is categorized into blood products, biological fluids, cell lines, human tissue and, nucleic acids. The blood products have a major contribution in the market owing to their increasing demand in various research studies.

Biobanking Market by Storage Type 

Based on the type of storage, the market is segmented into automated storage and manual storage. The manual storage is projected to account for the largest share and the automated storage is anticipated to witness the highest CAGR during the forecast period.

Biobanking Market by Application

Based upon application, the market is segmented into clinical research, life science research and regenerative medicines. Owing to the growing research in regenerative medicine and increasing demand for biosamples, regenerative medicine is estimated to account for the largest share of this market during the forecast period.

Biobanking Market by Region

The global biobanking market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). Currently, North America dominates the biobanking market owing to the factors such as increasing research activities, heavy investments in the field of genomics, and growing interest in biomarker discovery. Moreover, the Asia Pacific region is anticipated to propel the biobanking market during the forecast period, with a significant CAGR. Presence of a large population base in this region, especially in countries like India and China, will boost up the market. Furthermore, increasing infrastructural facilities in life sciences, as well as a rise in funds by governmental organizations in this field, is likely to drive the market in this region.

Biobanking Market Prominent Players

The key players in the global biobanking market are Thermo Fisher Scientific Inc., PHC Holdings Corporation, QIAGEN N.V., Becton, Dickinson and Company, Merck KGaA, Hamilton Company, Avantor, Inc., Tecan Group Ltd., BioCision, Promega Corporation among others.

 

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.  Market Classification
      2.  Geographic Scope
      3.  Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
    3. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.  Secondary Sources
      2.  Primary Sources
    4. Market Estimation Methodology
      1.  Bottoms Up Approach
      2.  Top Down Approach
    5. Data Validation and Triangulation
      1.  Market Forecasting Model
      2.  Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Technological Advancements
    2.   Research Landscape Assessment  
  6. GLOBAL BIOBANKING MARKET - ANALYSIS & FORECAST, BY PRODUCT & SERVICES
    1. Equipment
      1. Sample Analysis Equipment
      2. Sample Processing Equipment
      3. Sample Transport Equipment
      4. Storage Equipment
    2. Consumables
      1. Analysis Consumables
      2. Processing Consumables
      3. Collection Consumables
      4. Storage Consumables
    3. Services
      1. Supply Services
      2. Transport Services
      3. Processing Services
      4. Storage Services
    4. Software
  7. GLOBAL BIOBANKING MARKET - ANALYSIS & FORECAST, BY SAMPLE TYPE
    1. Blood Products
    2. Biological Fluids
    3. Cell Lines
    4. Human Tissues
    5. Nucleic Acids
    6. Others
  8. GLOBAL BIOBANKING MARKET - ANALYSIS & FORECAST, BY STORAGE TYPE
    1. Automated Storage
    2. Manual Storage
  9. GLOBAL BIOBANKING MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Clinical Research
    2. Life Science Research
    3. Regenerative Medicine
  10. GLOBAL BIOBANKING MARKET - ANALYSIS & FORECAST, BY REGION
    1.   North America Biobanking Market
      1.  North America Market, By Country
        1. US
        2.  Canada
      2. North America Market Analysis & Forecast, By Product  & Services
      3. North America Market Analysis & Forecast, By Sample Type
      4. North America Market Analysis & Forecast, By Storage Type
      5. North America Market Analysis & Forecast, By Application
    2. Europe Biobanking Market
      1. Europe Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Market Analysis & Forecast, By Product  & Services
      3. Europe Market Analysis & Forecast, By Sample Type
      4. Europe Market Analysis & Forecast, By Storage Type
      5. Europe Market Analysis & Forecast, By Application
    3. Asia Pacific Biobanking Market
      1. Asia Pacific Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Market Analysis & Forecast, By Product  & Services
      3. Asia Pacific Market Analysis & Forecast, By Sample Type
      4. Asia Pacific Market Analysis & Forecast, By Storage Type
      5. Asia Pacific Market Analysis & Forecast, By Application
    4.   Rest of the World (ROW) Biobanking Market
      1. Rest of the World Market, By Country/ Region
        1.  Latin America
        2.  Middle East & Africa
      2. Rest of the World Market Analysis & Forecast, By Product  & Services
      3. Rest of the World Market Analysis & Forecast, By Sample Type
      4. Rest of the World Market Analysis & Forecast, By Storage Type
      5. Rest of the World Market Analysis & Forecast, By Application
  11. COMPETETIVE LANDSCAPE
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment
      1. New Product & Services Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  12. COMPANY PROFILES (Business Overview, Products & Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
    1. Thermo Fisher Scientific Inc.
    2. PHC Holdings Corporation
    3. QIAGEN N.V.
    4. Becton, Dickinson and Company
    5. Merck KGaA
    6. Hamilton Company
    7. Avantor, Inc.
    8. Tecan Group Ltd.
    9. BioCision
    10. Promega Corporation

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain